ReviewMolecular medicine (Cambridge, Mass.)2023
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases.
Wenxuan Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
62 papers cite itlatest 60 shown
this paperpooled itcites it